Cerebral palsy (CP) is a group of permanent movement disorders caused by brain injury or abnormal development during early life. It affects muscle tone, coordination, and posture, often accompanied by sensory and cognitive challenges. While cerebral palsy is non-progressive, its impact can evolve throughout a person’s lifespan, requiring lifelong management and support.

The Cerebral Palsy session focuses on understanding the neuropathology, early detection, and multidisciplinary treatment strategies for CP. Researchers are investigating prenatal and perinatal risk factors, including hypoxic injury, infection, and genetic mutations. Advances in neonatal neuroimaging and early therapeutic interventions have improved early diagnosis and neuroprotection outcomes.

At the Cerebral Palsy Conference, experts highlight innovative therapies such as constraint-induced movement therapy, robot-assisted rehabilitation, and neurostimulation techniques. Discussions also include spasticity management through pharmacologic and surgical methods like selective dorsal rhizotomy and intrathecal baclofen therapy.

This session emphasizes collaboration among pediatric neurologists, rehabilitation therapists, orthopedic specialists, and caregivers. Participants will explore developmental neuroplasticity, assistive technology, and patient-specific care models improving functional independence and quality of life.

Insights from Pediatric and Developmental Neurology are advancing preventive, diagnostic, and therapeutic strategies that enhance outcomes for children living with CP.